Alzamend Neuro Inc (ALZN)

NASDAQ
0.95
+0.01(+1.25%)
After Hours
0.93
-0.02(-1.72%)
- Real-time Data
  • Volume:
    179,334
  • Day's Range:
    0.93 - 0.95
  • 52 wk Range:
    0.80 - 12.14

ALZN Overview

Prev. Close
0.93
Day's Range
0.93-0.95
Revenue
-
Open
0.93
52 wk Range
0.8-12.14
EPS
-0.11
Volume
179,334
Market Cap
88.02M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
826,133
P/E Ratio
-
Beta
-
1-Year Change
-89%
Shares Outstanding
93,019,290
Next Earnings Date
Jun 29, 2022
What is your sentiment on Alzamend Neuro?
or
Market is currently closed. Voting is open during market hours.

Alzamend Neuro Inc Company Profile

Alzamend Neuro Inc Company Profile

Employees
5

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative diseases and psychiatric disorders. Its pipeline includes AL001, an ionic cocrystal technology delivering a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer’s and other neurodegenerative diseases, and psychiatric disorders; and AL002, a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient’s immunological system to combat Alzheimer’s. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsBuyStrong BuyStrong BuyBuySell
SummaryStrong BuyStrong BuyStrong BuyBuySell
  • any news
    0
    • buy!
      0
      • Anyone ?
        0
        • byebye
          0
          • what?
            0
            • Good news
              0